Results 221 to 230 of about 22,723 (239)
Some of the next articles are maybe not open access.
[Huntington's disease: trinucleotide disease or polyglutamine disease?].
Rinsho shinkeigaku = Clinical neurology, 1996Huntington's disease (HD) is associated with expansion of an unstable CAG repeat. Using antibodies against the synthetic peptide corresponding to the sequence of HD gene IT15, we have identified the HD gene product in normal lymphocytes as a approximately 350kDa protein by immunoblot analysis.
K, Ide, N, Nukina, I, Kanazawa
openaire +1 more source
Drosophila Models of Polyglutamine Diseases
2003H Y Edwin, Chan, Nancy M, Bonini
openaire +2 more sources
Polyglutamine diseases and the risk of cancer
The Lancet Oncology, 2012Mahmoud A, Pouladi, Michael R, Hayden
openaire +2 more sources
Polyglutamine Repeats in Neurodegenerative Diseases
Annual Review of Pathology: Mechanisms of Disease, 2019Vikram G Shakkottai, Roger L Albin
exaly
Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?
Journal of Molecular Cell Biology, 2010Osamu Onodera
exaly
Nihon rinsho. Japanese journal of clinical medicine, 2012
Kazuhiko, Tagawa, Hitoshi, Okazawa
openaire +1 more source
Kazuhiko, Tagawa, Hitoshi, Okazawa
openaire +1 more source
[Polyglutamine diseases: a pathologic view].
Rinsho shinkeigaku = Clinical neurology, 2004It has been widely accepted that there is a discrepancy between clinical features and lesion distribution evaluated by neuronal loss in the polyglutamine diseases including Huntington's disease and dentatorubral-pallidoluysian atrophy (DRPLA). Neuronal intranuclear inclusion (NII) is a characteristic feature of the polyglutamine diseases; however, its ...
openaire +1 more source